Overview
Alcohol and other drug (AOD) treatment services provide support to people regarding their use of alcohol or drugs. Treatment objectives can include reduction or cessation of alcohol or drug use as well as improvements to social and personal functioning. Assistance may also be provided to support the family and friends of people who use alcohol or drugs.
Featured summary
In Australia, publicly funded alcohol and other drug treatment services are available in all states and territories—most are funded by state and territory governments, and some are funded by the Australian Government.
Clients seeking treatment for their own drug use nominate a principal drug of concern, and additional drugs where applicable, which may be related to licit drug use (the use of legal drugs in a legal manner, including tobacco smoking and alcohol consumption) or illicit drug use. Illicit drug use refers to the:
- use of illegal drugs—those prohibited from manufacture, sale or possession in Australia, such as cannabis, cocaine, heroin and ecstasy misuse, non-medical or extra-medical use of pharmaceuticals—drugs that are available from a pharmacy, over-the-counter or by prescription, which may be subject to misuse, such as opioid-based pain relief medications, opioid substitution therapies, benzodiazepines, over-the-counter codeine and steroids
- use of other psychoactive substances—legal or illegal, which can potentially be used in a harmful way, for example, kava, or inhalants such as petrol, paint or glue (but not including tobacco or alcohol) (DoH 2017).
Depending on a client's circumstances, services can be delivered in residential or non-residential settings and include treatment such as detoxification and rehabilitation, counselling, and pharmacotherapy.
Opioid pharmacotherapy is one of the main treatment options for dependence on opioid drugs, such as heroin and morphine. Treatment involves replacing the opioid drug of dependence with a legally obtained, longer-lasting opioid that is taken orally. In Australia, clients attend dosing point sites (for example, pharmacies) regularly to take the dose of their prescribed medication under the supervision of a pharmacist or other health professional.
Reference
DoH (Department of Health) 2017. The National Drug Strategy 2017–2026. Canberra: Commonwealth of Australia.
Featured reports
Latest findings
Around 131,500 clients sought AOD treatment in 2022–23
Of the 235,500 AOD treatment episodes provided, counselling was the most common treatment type (34%)
Alcohol remains the most common principal drug of concern for which clients sought treatment
55,741 clients received opioid pharmacotherapy treatment on a given day across Australia in 2022
There were 3,189 opioid pharmacotherapy dosing sites where clients receive treatment in Australia
There were 2,982 authorised opioid pharmacotherapy prescribers
More reports and statistics on AODTS can be found under Alcohol, Illicit use of drugs and Smoking.